ANIXA BIOSCIENCES, INC. Unrealized Gain (Loss) on Investments
ANIXA BIOSCIENCES, INC. (ANIX) reported Unrealized Gain (Loss) on Investments of -$1.75 million for the 3-month period ending 2013-07-31, per its 10-Q/A filed 2013-09-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2013-09-20
- ANIXA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2013-07-31 was -$1.75M.
- ANIXA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2013-04-30 was $290.19K.
- ANIXA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2013-01-31 was $1.00M.
- ANIXA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2012-07-31 was -$261.77K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month |
|---|---|---|---|
| 2013-07-31 | -$1.75M 10-Q/A · filed 2013-09-20 | -$1.46M derived: sum of 2 quarters · filed 2013-09-20 | -$459.23K 10-Q/A · filed 2013-09-20 |
| 2013-04-30 | $290.19K 10-Q/A · filed 2013-06-19 | $1.29M 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $1.00M 10-Q/A · filed 2013-03-25 | ||
| 2012-07-31 | -$261.77K 10-Q/A · filed 2013-09-20 | -$779.33K 10-Q/A · filed 2013-09-20 | |
| 2012-07-30 | -$261.77K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-09-14 | -$674.63K derived: sum of 2 quarters · filed 2013-06-19 | -$779.33K 10-Q · filed 2012-09-14 |
| 2012-04-30 | -$412.85K 10-Q/A · filed 2013-06-19 | -$517.56K 10-Q/A · filed 2013-06-19 | |
| 2012-01-31 | -$104.71K 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |